Opioid use disorder (OUD) is a growing public health problem among pregnant and parenting people in the U.S. Between 1999 and 2014, the number of pregnant women with OUD increased by more than four times.
EC approves Novartis’ Kisqali for early breast cancer treatment
Novartis developed the therapy under a research partnership with Astex Pharmaceuticals. Credit: © 2024 Novartis AG. The European Commission (EC) has granted approval to Novartis‘
November 27, 2024